WWW - Posts tagged PRG at BloggingStocks

PRG posts

Analyst upgrades, downgrades and initiations: ALU, BJ, CPB, KMX, PGR

Posted Jun 22nd 2009 11:40AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Analyst Initiations

Analyst Upgrades

McAdams Wright expects Dendreon's (NASDAQ: DNDN) near-term momentum to continue but has long-term concerns that Street estimates are too high. The firm upgraded shares to Hold from Sell.
JPMorgan upgraded Ameristar Casinos (NASDAQ: ASCA) to Overweight from Neutral to reflect valuation, potential catalysts from Colorado's easing gaming regulations, and the company's strong free cash flow. The firm raised its target on shares to $24 from $20.
Citigroup upgraded Valspar (NYSE: VAL) to Hold from Sell after channel checks indicated paint demand is shifting to big-box retailers, the company's primary sales channel. The firm raised its target on shares to $22 from $19.
Vulcan Materials (NYSE: VMC) was upgraded to Buy from Neutral at UBS.
Altera (NASDAQ: ALTR) was raised to Outperform from Sector Perform at RBC Capital.
Spectra Energy (NYSE: SEP) was upgraded to Neutral from Sell at Goldman.

Continue reading Analyst upgrades, downgrades and initiations: ALU, BJ, CPB, KMX, PGR

Analyst upgrades 7-23-07: AFL, AMGN, BUD and TIVO

Posted Jul 23rd 2007 10:30AM by Kevin Shult (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Good news, AFLAC Inc (AFL), Anheuser-Busch InBev (BUD), Amgen Inc (AMGN)

MOST NOTEWORTHY: Anheuser-Busch (BUD), Imax Corp (IMAX), Amgen (AMGN), Fifth Third Bancorp (FITB) and TiVO (TIVO) were today's noteworthy upgrades:

Citigroup upgraded shares of Anheuser-Busch (NYSE: BUD) to Hold from Sell as they see a 70% chance of an alliance between Anheuser-Busch and InBev in the next two years; they believe such a merger would create a market leader.

Merriman upgraded IMAX Corp (NASDAQ: IMAX) to Buy from Neutral after IMAX removed its overhang by completing SEC filings, while fundamentals have remained strong.

Citigroup upgraded Amgen (NASDAQ: AMGN) to Hold from Sell to reflect the potential for CMS to roll back proposed reimbursement cuts in oncology, an improving risk/reward profile and the potential for positive phase 3 denosumab data by year-end.

Stifel raised its rating on Fifth Third Bancorp (NASDAQ: FITB) to Hold from Sell on valuation.

Kaufman upgraded TiVO (NASDAQ: TIVO) to Buy from Sell as indicators of the change in its business model suggest a positive transaction. The firm feels the the EchoStar (DISH) litigation provides an attractive risk/reward potential, creating an attractive entry point...

OTHER UPGRADES: